The HCC patient-journey study: a prospective, adaptive, master protocol, to assess the value of the available sequences of treatment for patients with advanced hepatocellular carcinoma. The Journey of liver cancer patient - J-LI
Progression-free survival (PFS), overall response rate (ORR), quality of life (QoL), and safety/tolerability, financial toxicity, prognostic and predictive value of geriatric assessment parameters in the elderly population assessed through ADL, IADL, and G8 questionnaires, healthcare resource utilization, treatment costs, cost-effectiveness and cost-utility
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.